Maintaining aspirin use during kidney stone lithotripsy
Official title: Maintenance of an Antiaggregation by Acetylsalicylic Acid, Less or Equal to 250mg While a Extracorporeal Lithotripsy (ECL) Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study
Run by University Hospital, Clermont-Ferrand · NCT03437057 · Data updated 2026-11-12
This study is testing if continuing aspirin use during kidney stone treatment helps patients feel better and have fewer complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand) |
| Status | Recruiting |
| Started | January 8, 2018 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | January 17, 2025 |
| Trial ID | NCT03437057 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with at least one renal stone requiring ECL who are currently taking aspirin as monotherapy.
✕Probably not a fit
Patients with bleeding disorders, those on anticoagulant therapy, or those requiring multiple ECL sessions will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and effectiveness of continuing acetylsalicylic acid (aspirin) treatment during extracorporeal lithotripsy (ECL) for patients with renal lithiasis. Patients over 18 years old, who are on a stable dose of aspirin, will be monitored before, during, and after the ECL procedure to assess pain levels, blood pressure, and any adverse reactions. The study aims to determine if maintaining aspirin therapy impacts the outcomes of the lithotripsy procedure, particularly in terms of stone clearance and hematoma formation.
Why it matters
Potential benefit: If successful, this study could allow patients to continue their antiplatelet therapy safely during kidney stone treatment, potentially reducing complications.
How similar studies have gone: While similar studies on antiplatelet therapy during surgical procedures exist, this specific approach to ECL and aspirin use is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Over 18 yo patients * Patients with 1 renal lithiasis (at least) requiring treatment with extracorporeal lithotripsy * Patients taking Kardégic 75 (monotherapy Exclusion Criteria: * Patients with known (or previously known) bleeding disorders on the pre-treatment assessment * Patients with anticoagulant therapy or other anti-aggregating therapy (eg Kardegic at 75mg, AVK, NACO, LMWH, HNF, P2Y12 inhibitor) * Patients with another contrindication to the ECL. * Patients with prescription of more than the outset 1 ECL session * Tutelage, curatorship, justice safeguarding, deprived of liberties, unaffiliated SS, impaired comprehension abilities, pregnant and lactating women.
Where it's running
-
CHU Clermont-Ferrand
Clermont-Ferrand, France Recruiting
Study contacts
- Study coordinator: Lise LACLAUTRE
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: 04 73 75 49 63
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ovarian drilling via vNOTES laparoscopy for PCOS patients
This study tests whether drilling the ovaries using vNOTES laparoscopy can help women with PCOS who did not respond to first-line medicines.
-
Work and leisure physical activity short questionnaire validation
This study tests a shorter questionnaire to see if it accurately measures work and leisure activity and sedentary time by comparing it with a well-established reference questionnaire.
-
AI-assisted embryo selection on day 5 in IVF for infertility
This trial tests whether an AI-based embryo selection tool can help pick the best embryo for transfer on day 5 in IVF/ICSI to improve pregnancy chances for people with infertility.
-
Endothelial Function in Healthy Women Over 50 See How Your Blood Vessels Work
This study tests whether flow-mediated dilation (FMD) measurements in healthy women aged 50 and older can establish reference values.
-
Preventive habits of physicians (PREVMED) so doctors’ cancer screening and lifestyle advice patterns
This study tests how doctors and medical residents practice prevention with patients, and what personal or work factors might influence those practices.
-
Impact of Phosphate Supplementation on FGF23 Levels in Hypophosphatemia Patients
This study tests whether giving phosphate affects FGF23 levels in adults with low phosphate who need supplementation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.